NIH Stem Cell Information
Used as an institutional baseline for definitions, basic properties and high-level field framing.
Sources and method
How this site weighs evidence.
For stem cells, the source type matters almost as much as the content. Institutional pages, guidelines, official center profiles and consumer alerts carry a different weight than promotional copy or generic news coverage.
HierarchyInstitutional, clinical, basic
ChecksRoles, regulatory status, dates
GoalSeparate evidence, context and marketing
Method
Core editorial rules
Use institutional or official pages for regulation, roles, centers and program descriptions.
Keep basic research, preclinical work, clinical trials and standard care separate.
Avoid absolute rankings for doctors and institutions unless transparent comparable metrics exist.
State clearly when a source only documents public presence or outreach rather than clinical superiority.
Questions worth asking
- Is the source institutional, scientific or commercial?
- Is it discussing research, trials or established care?
- Is the cellular product clearly defined?
- Are limits, risks and regulatory status explicit?
- Is the source recent enough for this field?
Source list
Main references used across the site
- NIH Stem Cell Information
- NIH Common Fund: Stem Cells
- MedlinePlus: Stem Cells
- FDA consumer information on regenerative medicine therapies
- FDA consumer alert on regenerative medicine products
- ISSCR Guidelines
- EuroStemCell on unproven stem cell therapies
- San Raffaele official program page
- San Matteo official transplant unit page
- Bambino Gesu official oncohematology page
- Holostem official page
- Universita Europea di Roma: Fernando Colao
- GVM: Fernando Colao
Source records
How a few key sources were weighted
FDA consumer information and alerts
Used for warnings on unapproved products, patient risk and the need to separate clinical trials from commercial offerings.
ISSCR Guidelines
Used to anchor the site to an international professional framework on stem cell research and clinical translation.
Evidence hierarchy
What should weigh more when the question is clinical
Institutional level
FDA alerts, ISSCR guidelines and official hospital or university pages carry the most weight for regulatory status, program structure and documented roles.
Clinical level
Hospital transplant units and official clinical programs help document activity and indications, but they are not a substitute for comparative outcome evidence.
Basic science level
Laboratory research and explanatory articles are essential for understanding the field, but should not be confused with proof of routine clinical effectiveness.
Linked references
Two companion pages worth reading with this method page
Advanced glossary
Defines terms such as pluripotency, iPSCs, organoids and autologous use with cautious wording and declared sources.
Scientific FAQ
Turns the site's evidence rules into concrete answers about claims, trials and interpretive limits.